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ABSTRACT
Covariate balance is crucial for unconfounded descriptive or causal comparisons. However,
lack of balance is common in observational studies. This article considers weighting strategies
for balancing covariates. We define a general class of weights—the balancing weights—that
balance the weighted distributions of the covariates between treatment groups. These weights
incorporate the propensity score to weight each group to an analyst-selected target popula-
tion. This class unifies existing weighting methods, including commonly used weights such as
inverse-probability weights as special cases. General large-sample results on nonparametric es-
timation based on these weights are derived. We further propose a new weighting scheme, the
overlap weights, in which each unit’s weight is proportional to the probability of that unit being
assigned to the opposite group. The overlap weights are bounded, and minimize the asymp-
totic variance of the weighted average treatment effect among the class of balancing weights.
The overlap weights also possess a desirable small-sample exact balance property, based on
which we propose a new method that achieves exact balance for means of any selected set of
covariates. Two applications illustrate these methods and compare them with other approaches.
KEY WORDS: balancing weights, causal inference, clinical equipoise, confounding, exact bal-
ance, overlap weights
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1 Introduction
Unconfounded comparison between groups is a central goal in many observational studies.
Comparative effectiveness studies aim to estimate the causal effect of a treatment or interven-
tion unconfounded by differences between characteristics of those assigned to the treatment
and control conditions under current practice. Noncausal descriptive studies often concern a
controlled and unconfounded comparison of two populations, such as comparing outcomes
among populations of different races or of cohorts in different years while giving the compar-
ison groups similar distributions of some important covariates. Whether the purpose of the
study is causal or descriptive, comparisons between groups can be biased when the groups lack
balance, that is, have substantially different distributions of relevant covariates.
Standard parametric adjustment by regression is often sensitive to model misspecification
when groups differ greatly in observed characteristics (Rubin, 1979). A commonly used non-
parametric balancing strategy is weighting, which applies weights to the sample of units in each
treatment group to match the covariate distribution of a target population, and the comparison is
made between the weighted outcomes. The literature on weighting (e.g. Robins and Rotnitzky,
1995; Hahn, 1998; Robins et al., 2000; Hirano and Imbens, 2001; Hirano et al., 2003; Imbens,
2004; Crump et al., 2009) has been dominated by the inverse-probability weights (IPW), orig-
inating from survey research. A special case of IPW is the Horvitz-Thompson (HT) weight
(Horvitz and Thompson, 1952), which for each unit is the inverse of the probability of that unit
being assigned to the observed group. The HT weights correspond to estimands defined on
the population represented by the combined treatment and control groups, such as the average
treatment effect (ATE) in causal studies. Variants of IPWs targeting at treatment effects on the
treated group (ATT) or other subpopulations have also been commonly used (e.g. Hirano and
Imbens, 2001; Li and Greene, 2013).
The ATE and ATT estimands are widely accepted, largely because they represent effects on
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easy-to-interpret target populations, and estimators of these effects possess desirable statistical
properties. For example, Manski (1990) showed that in cases where the outcome variable is
bounded, sharp bounds on the ATE and ATT can be derived. However the automatic focus on
these estimands is often questionable in practice. First, ATE and ATT may correspond to the
effect of an infeasible intervention. For example, the ATE corresponds to the effect of switch-
ing every unit in the study population from one treatment to the other; such a complete change
in treatment is rarely conceivable in medical studies, where the treatment might be known to be
harmful to patients with certain characteristics. Imbens and Wooldridge (2009) made a similar
argument in the context of a job training program. Second, as Rosenbaum (2012) explains,
“. . . often the available data do not represent a natural population, and so there is no compelling
reason to estimate the effect of the treatment on all people recorded in this source of data. . . ”
In such cases, applying the HT or ATT weights to the observed sample might not yield an es-
timate of the average treatment effect in the scientifically appropriate target population. Third,
researchers commonly exclude some units from the final analysis, e.g. unmatched units or
units with extremely large weights. The remaining sample may only represent a subpopula-
tion of the original targeted population and this subpopulation can vary from study to study.
Fourth, with ATE and ATT extreme probabilities (close to 0 or 1) introduce extreme IPWs,
with adverse finite-sample consequences such as poor balance and large variance (Busso et al.,
2014). Lastly, in causal inference there is ample precedent for prioritizing covariate balance
between treatment groups over generalizability to a recognizable target population, as demon-
strated by the huge body of experimental evidence based on randomization of treatment within
a non-randomly selected (in many cases convenience) sample.
A recent strand of literature suggests shifting the focus from ATE or ATT to subpopulations
with sufficient overlap in covariates between treatments. Crump et al. (2009) advocated focus-
ing on the “optimal” subpopulation for which the average treatment effect can be estimated
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with the smallest variance, approximated by discarding all units with estimated propensity
scores outside the range [α, 1−α]. However, as illustrated in Section 5.3, this approach can be
sensitive to the choice of the cutoff point, for which there is no strong theoretical guidance, and
can possibly exclude much of the study sample. In an example in Crump et al. (2006), setting α
to 0.1 removes 90% of the study sample; the same will occur if one of the groups is much larger
than the other, driving propensity scores close to 0 or 1. Moreover, the propensity-score-based
cutoff criterion may be difficult to interpret in practice (Traskin and Small, 2011).
In this article, we define the class of balancing weights that balance the distributions of
covariates between comparison groups for any pre-specified target population. We stress that
the choice of target population distribution is neither automatic nor restricted to the ATT and
ATE. Within this class of weights, we introduce the overlap weights, which weight each unit
proportional to its probability of assignment to the opposite group. Unlike the IPWs, the over-
lap weights are bounded between 0 and 1 so the weighted distributions are always integrable.
Under mild conditions, the overlap weights minimize the asymptotic variance of the nonpara-
metric estimate of the weighted average treatment effect within the class of balancing weights.
Applications of these weights have appeared in the health services literature at least since
2001 (Schneider et al., 2001) but without theoretical development. Large-sample results on
overlap weights appeared in the working paper of Crump et al. (2006), who regarded the sub-
population defined by the overlap weights as merely a device to “acknowledge and address the
difficulties in making inferences about the population of primary interest.” In contrast, we fore-
ground the overlap weights as defining a population of substantial clinical or policy interest,
namely the subpopulation which currently receives either treatment in substantial proportions.
We illustrate the substantive relevance of this target population and estimand in two applica-
tions, one concerning racial disparities in medical expenditure and one concerning evaluation
of a medical treatment. Overlap weights estimated from a logistic model also have a useful
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small-sample property: they yield exact balance between groups in the means of each covari-
ate included in the model. This property can be exploited in a hybrid that imposes exact balance
on a matched sample by reweighting it.
Section 2 introduces the general framework of balancing weights and defines corresponding
estimands. Section 3 presents three large-sample properties of the nonparametric weighting
estimators. In Section 4 we propose the overlap weights, present a small-sample exact balance
result, and describe the new matching-weighting hybrid method. In Section 5, we illustrate the
proposed methods through simulations and two real applications. Section 6 concludes.
2 Balancing Weights
Consider a sample or finite population of n units, each belonging to one of two groups for which
covariate-balanced comparisons are of interest, possibly defined by a treatment. Let Zi = z be
the binary variable indicating membership in groups that may be labeled treatment (z = 1) and
control (z = 0). For each unit, an outcome Yi and a set of covariates Xi = (Xi1, ..., XiK) are
observed. The propensity score (Rosenbaum and Rubin, 1983) is the probability of assignment
to the treatment group given the covariates, e(x) = Pr(Zi = 1|Xi = x).
In descriptive comparisons, “assignment” is to a nonmanipulable state defining membership
in one of two groups, and a common objective is to evaluate the average difference in the
outcome in two groups with balanced distributions of covariates. We first define the conditional
average controlled difference (ACD) (Li et al., 2013) for a given x as,
τ(x) ≡ E(Y |Z = 1, X = x)− E(Y |Z = 0, X = x). (1)
For causal comparisons, we adopt the potential outcome framework (Rubin, 1974, 1978;
Imbens and Rubin, 2015). Assuming the standard Stable Unit Treatment Value Assumption
(SUTVA) (Rubin, 1980), which states that the potential outcomes for each unit are unaffected
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by the treatment assignments of other units, each unit has potential outcomes {Yi(z), z = 0, 1}
corresponding to the possible treatment levels, of which only one is observed: Yi = ZiYi(1) +
(1 − Zi)Yi(0). Under the unconfoundedness assumption, that is, {Y (0), Y (1)} ⊥ Z|X , we
have Pr(Y (z)|X) = Pr(Y |X,Z = z) for z = 0, 1, so τ(x) in (1) is a causal estimand—the
average treatment effect (ATE) conditional on x:
τ(x) = E[Y (1)− Y (0)|X = x]. (2)
Estimation of either comparison requires the probabilistic assignment assumption, 0 < e(X) <
1, which states that the study population is restricted to values of covariates for which there
can be both control and treated units. Assignment mechanisms assuming both probabilistic
assignment and unconfoundedness are strongly ignorable (Rosenbaum and Rubin, 1983).
Typically in either descriptive or causal comparisons the (potential) outcomes are compared
not for a single x but rather averaged over a hypothesized target distribution of the covariates.
Assume the marginal density of the covariates X , f(x), exists, with respect to a base measure
µ (a product of counting measure with respect to categorical variables and Lebesgue measure
for continuous variables). We then represent the target population density by f(x)h(x), where
h(·) is pre-specified function of x, and define a general class of estimands by the expectation
of the conditional ACD or ATE τ(x) over the target population:
τh ≡
∫
τ(dx)f(x)h(x)µ(dx)∫
f(x)h(x)µ(dx)
. (3)
For descriptive comparisons, τh is the weighted ACD, and for causal comparisons it is the
weighted average treatment effect (WATE) (Hirano et al., 2003), the term we use henceforth
for either case.
Let fz(x) = Pr(X = x|Z = z) be the density of X in the Z = z group, then
f1(x) ∝ f(x)e(x), and f0(x) ∝ f(x)(1− e(x)).
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For a given h(x), to estimate τh, we can weight fz(x) to the target population using the follow-
ing weights (proportional up to a normalizing constant): w1(x) ∝
f(x)h(x)
f(x)e(x)
= h(x)
e(x)
, for Z = 1,
w0(x) ∝ f(x)h(x)f(x)(1−e(x)) = h(x)1−e(x) , for Z = 0.
(4)
We call this class of weights defined in (4) the balancing weights because they balance the
weighted distributions of the covariates between comparison groups:
f1(x)w1(x) = f0(x)w0(x) = f(x)h(x). (5)
The function h can take any form, and all weights that balance the covariate distributions
between groups can be specified within this class.
Specification of h defines the target population and estimands and determines the weights.
Statistical, scientific and policy considerations all may come into play. When h(x) = 1, the
corresponding target population f(x) is the combined (treated and control) population, the
weights (w1, w0) are the HT weights (1/e(x), 1/(1 − e(x))), and the estimand is the ATE for
the combined population, τ ATE = E[Y (1)− Y (0)]. When h(x) = e(x), the target population is
the treated subpopulation, the weights are (1, e(x)/(1− e(x))), and the estimand is the average
treatment effect for the treated (ATT), τ ATT = E[Y (1)− Y (0)|Z = 1]. When h(x) = 1− e(x),
the target population is the control subpopulation, the weights are ((1− e(x))/e(x), 1), and the
estimand is the average treatment effect for the control (ATC), τ ATC = E[Y (1)− Y (0)|Z = 0].
By choosing h from the class of indicator functions, one can define the ATE for truncated
subpopulations of substantive interest or with desirable theoretical properties. For example,
Crump et al. (2009) recommended use of h(x) = 1(α < e(x) < 1−α) with a pre-specified α ∈
(0, 1/2) that defines a subpopulation with sufficient overlap of covariates between two groups.
Li and Greene (2013) proposed to use h(x) = min{e(x), 1− e(x)}, which defines a weighting
analogue to pair matching; a similar notion was discussed earlier in Dehejia and Wahba (1999).
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target population h(x) estimand weight (w1, w0)
combined 1 ATE
(
1
e(x)
, 1
1−e(x)
)
[HT]
treated e(x) ATT
(
1, e(x)
1−e(x)
)
control 1− e(x) ATC
(
1−e(x)
e(x)
, 1
)
overlap e(x)(1− e(x)) ATO (1− e(x), e(x))
truncated combined 1(α < e(x) < 1− α)
(
1(α<e(x)<1−α)
e(x)
, 1(α<e(x)<1−α)
1−e(x)
)
matching min{e(x), 1− e(x)}
(
min{e(x),1−e(x)}
e(x)
, min{e(x),1−e(x)}
1−e(x)
)
Table 1: Examples of balancing weights and corresponding target population and estimand
under different h.
These examples are summarized in Table 1. Formulation (4) also allows application-specific
choices of h that are not functions of the propensity score, possibly to select a subpopulation
of interest (like an age range) or to match its covariate distribution.
3 Large-sample Properties of Nonparametric Estimators
Here we establish properties of the sample estimator of WATE,
τˆh =
∑
iw1(xi)ZiYi∑
iw1(xi)Zi
−
∑
iw0(xi)(1− Zi)Yi∑
iw0(xi)(1− Zi)
(6)
where the sum is over a sample drawn from density f(x). Proofs of the following three large-
sample results regarding τˆh are in the Appendix; a rigorous development of these and other
properties of nonparametric estimators under the required regularity conditions appears in Im-
bens (2004) and Crump et al. (2006).
Theorem 1. τˆh is a consistent estimator of τh.
The next result concerns the component of variation due to residual (model) variation in
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τˆh conditional on the sampled covariate design points X = {x1, . . . , xn}, the first term of the
decomposition V[τˆh] = ExV[τˆh | X] + Vx E[τˆh | X], showing that it can be characterized
after making only limited assumptions about residual variances, as in the Corollary below. The
second term arises from the dependence of the expectation of (6) on the sample, and estimating
it involves the outcome model (associations between Y (z) and x). However, as Imbens (2004)
argues, individual variation is typically much larger than conditional mean variation, so the
benefit of further optimizing the weights by a preliminary look at the outcomes typically would
not justify the risk of biasing model specification to attain desired results. Hence our weighting
strategy is based on general results concerning the first term.
Theorem 2. As n→∞, the expectation (over possible samples of covariate values) of the
conditional variance of the estimator τˆh given the sample X = {x1, . . . , xn} converges:
n · ExV[τˆh | X] →
∫
f(x)h(x)2 [v1(x)/e(x) + v0(x)/(1− e(x))]µ(dx)
/
C2h, (7)
where vz(x) = V[Y (z) | X] and Ch =
∫
h(x)f(x)dµ(x) is a normalizing constant.
Consequently, if the residual variance is assumed to be homoscedastic across both groups,
v1(x) = v0(x) = v, then the asymptotic variance of τˆh simplifies to
n · ExV[τˆh | X]→ v/C2h
∫
f(x)h(x)2µ(dx)
e(x)(1− e(x)) . (8)
Corollary 1. The function h(x) ∝ e(x)(1 − e(x)) gives the smallest asymptotic variance
for the weighted estimator τˆh among all h’s under homoscedasticity, and as n→∞,
n ·minh{ExV[τˆh | X]} → v/C2h
∫
f(x)e(x)(1− e(x))µ(dx).
In applications, the true propensity score e is unknown and is replaced by the estimated
propensity score eˆ. As shown in Rosenbaum (1987) and Hirano et al. (2003), a consistent esti-
mate of the propensity score in fact leads to more efficient estimation than the true propensity
score.
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These theoretical results have important practical consequences for propensity score weight-
ing analysis. First, calibration of the propensity score model is important: the predicted and
empirical rates of treatment assignment should agree in relevant subsets of the covariate space,
or else covariate balance cannot be attained. A simple check is to compare predicted and ob-
served rates in deciles (or other convenient intervals appropriate to the amount of data) of the
score distribution, in the spirit of Hosmer and Lemeshow (1980). If miscalibration is identified,
likely indicating a misfit in the link function, it can be corrected by ad hoc methods such as
ratio adjustment of each decile or adding indicator variables for the deciles of a trial model to
the final model (if the error is relatively small), or by fitting a flexible logistic spline model
relating the estimated linear predictor to treatment assignment. Estimates of treatment effect
by decile may also be of scientific interest for assessing association of treatment assignment
with treatment effect.
Second, a rich propensity score model, rather than a parsimonious one, is desirable, es-
pecially in causal inference applications, because the ignorability assumptions are likely to
be violated if the propensity score is only a simple logistic-linear function of the covariates
but both the outcome and assignment mechanism are functions of more complex interactions
or nonlinear terms. Given this, traditional statistical tests of goodness of fit are only mini-
mally relevant, because the objective of weighting is to balance covariate distributions in the
sample, not to make inferences about assignment probabilities in the population. Rather, the
limitation on model complexity is imposed by a bias-variance tradeoff. As the model becomes
more complex and therefore more predictive, propensity scores move toward 0 and 1, becom-
ing exactly 0 or 1 when the model discovers a separating plane in the data. Thus the weights
h(x) = e(x)(1 − e(x)) for many design points move toward zero, reducing the precision of
estimates. Analytic judgment is required to decide when further potential reductions in bias
are outweighed by the cost in variance. Nonetheless, maintaining the principle of separating
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design (the weighting model) from analysis (using outcome data), the variance inflation due to
model complexity can be approximated by calculating the corresponding ratio for an estimated
difference of weighted means assuming homoscedastic data; from (8) this is estimated by
(1/n1 + 1/n0)
−1 ∑
z=0,1
(
nz∑
i=1
w2zi
)/( nz∑
i=1
wzi
)2
, (9)
based on the “design effect” approximation of Kish (1965).
4 Overlap Weighting
4.1 The Overlap Weights
As is generally recognized, ATE is inestimable if the supports of the treatment groups are
different, making balanced comparisons impossible in the region of support for only one group.
Furthermore, the value and indeed the finiteness of the variance in (7) depends critically on the
distribution of e(x) close to 0 and 1 unless the denominator e(x) · (1− e(x)) is canceled by a
corresponding factor of h(x).
We define the overlap weights by letting h(x) = e(x)(1−e(x)), implying balancing weights w1(x) ∝ 1− e(x), for Z = 1,w0(x) ∝ e(x), for Z = 0. (10)
Following Corollary 1 and under its assumptions, the corresponding nonparametric estimator
τˆh has the minimum asymptotic variance among all balancing weights. Even if the outcomes
are moderately heteroscedastic, the overlap weights may have good efficiency while depending
only on design (covariate distributions in the treatment and control groups) and therefore being
defined prior to examining outcome data.
The overlap weights and the associated target population are illustrated in Figure 4.1 for
two univariate normal populations with equal size and variance. The upper panel illustrates the
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target population density f(x)h(x), which is greatest where the treated and control groups most
overlap. Hence, we call the corresponding WATE estimand τh the average treatment effect for
the overlap population (ATO). The lower panel shows that the ratio h(x) of target to combined
population peaks where the propensity score is 1/2, and these weights place more emphasis on
units with propensity score close to 1/2, who could be in either group, relative to those with
propensity scores close to 0 or 1.
Figure 1: Overlap weights for two normally-distributed groups with different means. In the
upper panel, the left and right solid lines, the thin and thick dashed lines represent the density
of the covariate in the control, treated, combined (h(x) = 1), and overlap weighted (h(x) =
e(x)(1 − e(x))) populations, respectively. In the lower panel, the two solid lines represent
w0(x), w1(x) and the dashed line represents h(x) = e(x)(1− e(x)).
The overlap weights, unlike the IPWs, are bounded and thus are less sensitive to extreme
weights. Compared to the common practice of truncating weights or discarding units, the
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overlap weights are continuously defined and avoid arbitrary choice of a cutoff for inclusion in
the analysis, as illustrated in an application in Section 5.3.
The variance-minimizing property of the overlap weighting implies that it adapts to any
distribution of covariates and propensities to define and answer the question that can be best
answered nonparametrically by the data at hand. These include several familiar special cases:
(1) if propensity to treatment is always small, ATO approximates ATT (for e(x) ≈ 0, (1 −
e(x), e(x)) ≈
(
1, e(x)
1−e(x)
)
); (2) in the opposite case where propensity to control is small, ATO
approximates ATC; (3) if treatment and control groups are nearly balanced in size and distri-
bution, ATO approximates ATE (for e(x) ≈ 1/2, (1− e(x), e(x)) ≈
(
.25
e(x)
, .25
1−e(x)
)
).
While the interpretation of the overlap distribution is specific to the application, the over-
lap population often represents a target population of intrinsic substantive interest, that is, the
units whose combination of characteristics could appear with substantial probability in either
treatment group. For example, in medicine, these may be patients for whom clinical consensus
is ambiguous or divided, who are said to be in equipoise between treatments, so research on
these patients may be most needed. In social policy, these might be the units whose treatment
assignment would be most responsive to a policy shift as new information is obtained. In gen-
eral, we may want to estimate a treatment effect or compare treatments on the subpopulation
of units that are the most similar between treatment groups.
Overlap weighting is in a sense asymptotically equivalent to matching. Consider a se-
quence of increasingly large datasets from some generating distribution. The weighting analy-
ses might be a sequence of increasingly complex models that converge to a saturated propen-
sity score model with indicators for each design point (or small neighborhood, for continuous
variables), while the matching criterion of closeness is correspondingly tightened to approach
exact matching on the same discrete design points or continuous neighborhoods. At this limit,
many-to-many matching would use weights equivalent to the overlap weights estimated from
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the saturated propensity score model. The overlap weights also have a natural connection to
regression with fixed effects for each design point. If the sample count for xi in group z = 0, 1
is nzi, the propensity score is e(xi) = n1i/(n0i + n1i) and the total overlap weight for each
group and hence of τˆ(xi) is n0in1i/(n0i + n1i); however this is exactly the precision weight
attached to Y¯1i − Y¯0i in the fixed-effects OLS model Yzi = αi + zτ + zi.
4.2 Exact Balance
Overlap weights based on a logistic propensity score model also have the following attractive
small-sample exact balance property (proved in the Appendix).
Theorem 3. When the propensity scores are estimated by maximum likelihood under a
logistic regression model, logit e(xi) = β0 +xiβ′, the overlap weights lead to exact balance in
the means of any included covariate between treatment and control groups. That is,∑
i xikZi(1− eˆi)∑
i Zi(1− eˆi)
=
∑
i xik(1− Zi)eˆi∑
i(1− Zi)eˆi
, for k = 1, . . . , K, (11)
where eˆi = {1 + exp[−(βˆ0 + xiβˆ′)]}−1 and βˆ = (βˆ1, ..., βˆk) is the MLE for the regression
coefficients.
While a main effects model guarantees exact equality between groups for the mean of each
included covariate, it is advisable to improve balance by including additional derived covari-
ates, guided by prior anticipation of possible effects on outcomes, as discussed at the end of
Section 3. These may include interactions and, for continuous variables, terms whose mean bal-
ance implies better matching of distributions, such as powers and products (to enforce equality
of moments) or spline terms. Note that the exact balance property applies for overlap weights
with propensity scores calculated with the canonical link under any generalized linear model,
including those for multi-group comparisons, e.g. multinomial logistic models for unordered
categorical outcomes or nested logistic models for ordinal outcomes.
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Theorem 3 is distinct from the exact balance result in Graham et al. (2012), which is on
inverse probability weights and does not provide the explicit form of the propensity score model
that would guarantee exact balance.
4.3 Combining Matching and Weighting: The “Tudor Solution”
Matching is the most widely used nonparametric adjustment method in practice. Based on the
exact balance property of the overlap weights (Theorem 3), we propose a hybrid approach that
combines matching and weighting — the “Tudor solution:” 2 matching followed by an overlap
weighting adjustment of the matched sample. In the first step, a matched sample is created
using any preferred approach (e.g., Mahalanobis distance matching within propensity score
calipers). In the second step, propensity scores are estimated by logistic regression within the
matched sample. Finally the treatment effect is estimated by applying the overlap weights to the
matched sample. This approach has the potential to combine the benefits of matching (nearness
of matched cases in multivariate space, including dimensions not controlled by the propensity
score model) and overlap weighting (exact balance for means of covariates in model). An anal-
ogous use of substitution sampling followed by regression adjustment in surveys was proposed
by Rubin and Zanutto (2002).
The Tudor solution might be most beneficial for high-dimensional data, where considerable
residual imbalance is possible due to its typical local sparseness. Removing mean imbalance
also removes the component of bias that would be estimated by a post-matching linear model,
but has the advantage of being conducted in the “design phase,” without knowledge and possi-
2The name “Tudor” evokes the Wars of the Roses (1455-1485), in which the houses of Lancaster and York
fought bitterly for the throne of England but victory went to a relatively remote Lancastrian claimant, the House
of Tudor, which through a strategic marriage ultimately united the claims of the rival houses. Here it refers to the
contention between weighting and matching in the statistical literature.
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ble manipulation of consequences for the estimates (Rubin, 2008).
5 Examples
5.1 Artificial Distributions
It is easy to construct examples in which the asymptotic variance (7) of estimates using HT
weights is infinite. For example, let x ∼ Uniform(0, 1), so f(x) ≡ 1 and let e(x) = x.
Here we illustratively compare HT, truncated HT (discarding units outside .1 < e < .9), and
overlap weighting estimators under more plausible assumed distributions by calculating vari-
ances of WATE estimates relative to the variance of the unweighted difference of means under
homoscedastic errors, for selected univariate distributions F1, F0 (Table 5.1). As required by
theory, variances with overlap weights are always the smallest. In scenario (1), there is a mod-
est shift of normal distributions; the HT estimator loses efficiency due to extreme weights in
the tails, which are excluded by the truncated estimator. With the larger shift between groups in
scenario (2), the HT variance is greatly inflated, but the truncated HT weighting removes most
of the extreme weights in the tails. In scenario (3) one sample is much larger than the other,
which skews the propensity score distribution. This causes an excessive truncation of one tail of
that distribution, increasing the variance of the truncated HT estimator. Adaptive modification
of truncation points might solve this problem, but no modifications are needed for the overlap
weighting estimator. In scenario (4) one group has much larger variance, again inflating the
HT variance, causing an explosion of weights in the tails of the narrower distribution.
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Relative variance
F1 F0 n0/n1 HT HT(trunc) Overlap
(1) N(0, 1) N(1, 1) 1 1.43 1.36 1.26
(2) N(0, 1) N(2, 1) 1 11.81 2.88 2.22
(3) N(0, 1) N(1, 1) 20 2.48 3.31 1.06
(4) N(0, 1) N(0, 202) 1 50.02 4.55 3.16
Table 2: Variances of WATE estimators relative to variance of difference of unweighted means,
under homoscedasticity and various covariate distributions.
5.2 A Causal Comparison: Right Heart Catheterization
Right heart catheterization (RHC) is a diagnostic procedure for directly measuring cardiac
function in critically ill patients. Though useful for directing immediate and subsequent treat-
ment, RHC can cause serious complications. In an influential study Connors et al. (1996)
used propensity score matching to study the effectiveness of right heart catheterization (RHC)
with observational data from Murphy and Cluff (1990). The study collected data on 5735
hospitalized adult patients at five medical centers in the U.S., 2184 of them assigned to the
treatment (Zi = 1), receipt of RHC within 24 hours of admission, and the remaining 3551
assigned to the control condition (Zi = 0). The outcome was survival at 30 days after ad-
mission. Based on information from a panel of experts, a rich set of variables potentially
relating to the decision to use RHC was collected. Connors et al. (1996) describes the study,
which has been since intensively re-analyzed (e.g. Hirano and Imbens, 2001; Crump et al.,
2009; Traskin and Small, 2011; Rosenbaum, 2012). The dataset is publicly available on
http://biostat.mc.vanderbilt.edu/wiki/pub/Main/DataSets/rhc.html.
The comparison in the RHC study is causal in the sense that the treatment—application of
RHC—is manipulable (Rubin, 1986). Among the 72 observed covariates (21 continuous, 25
binary, 26 dummy variables from breaking up 6 categorical covariates), distributions of several
key covariates differed substantially between the control and treatment groups (Hirano and
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Imbens, 2001, Table 2). For example, the treated group has a much higher average APACHE
(Acute Physiology and Chronic Health Evaluation) score, signifying greater severity of disease
at admission. The majority of the treated units have propensity scores larger than 0.5 and the
majority of the control units have propensity scores smaller than 0.5 (Crump et al., 2009, Figure
1). Most previous analyses focus on the ATT, that is, the average causal effect of applying RHC
for the patients who received RHC. In this study, as argued by Rosenbaum (2012), it would also
be of interest to estimate the effects of RHC for the “marginal” subjects, who might or might
not have been treated. Such estimates provide useful information for assigning treatments for
the population with no clear propensity to a group. Towards this goal, Rosenbaum (2012)
proposed an optimal matching strategy to choose the matches with the most treated subjects
that have adequate balance; Crump et al. (2009) limits the weighting analysis to a subsample
with the estimated propensity scores truncated to the interval [0.1, 0.9].
As in previous studies, we estimate the propensity score under a logistic model with main
effects of all the 72 covariates, based on which we calculate the HT, ATT and overlap weights.
We measure covariate mean balance for each covariate by the absolute standardized bias (ASB):
ASB =
∣∣∣∣∣
∑N
i=1 xiZiwi∑N
i=1 Ziwi
−
∑N
i=1 xi(1− Zi)wi∑N
i=1(1− Zi)wi
∣∣∣∣∣
/√
s21/N1 + s
2
0/N0, (12)
where s2z is the variance of the unweighted covariate in group z and Nz is the sample size
in group z. For unweighted data, this is the absolute value of the standard two-sample t-
statistic. We use an unweighted standard error in the denominator to allow for fair comparisons
across weighting methods: if the numerator and denominator were both to vary with weighting
method, a smaller ASB could be due to either better covariate balance or an increased standard
error. We calculate the ASB for each covariate after applying the overlap, HT, and ATT weights,
boxplots of which are displayed in Figure 2. Each set of weights improves mean balance
compared to the unweighted data, but the overlap weights clearly lead to the best balance; in
fact, here the ABS is exactly 0 for each covariate using overlap weights, based on Theorem 3.
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Figure 2: Boxplots for the absolute standardized differences for covariates under each weight-
ing method in the RHC study.
The causal effects estimated from τˆh using the three weights are shown in Table 3. For
comparison, we include results from the method of Crump et al. (2009) for ATT weighting
with optimal truncation, and the optimal matching method of Rosenbaum (2012). The standard
errors are estimated from the bootstrap procedure in Crump et al. (2009) with 5000 replicates.
All the estimates suggest that applying RHC leads to a higher mortality rate than not applying
RHC. Overlap weighting and optimal truncation lead to the smallest standard errors. Overlap
weighting and optimal matching give similar point estimates, around 10% larger than those
from the other methods.
unweighted overlap HT ATT Trunc. ATT Opt. match
Estimate ×102 -7.36 -6.54 -5.93 -5.81 -5.90 -6.78
SE ×102 1.27 1.32 2.46 2.67 1.43 1.56
Table 3: Estimates and standard errors obtained from different methods. Estimates using op-
timal truncation are from Crump et al. (2009), with estimated propensity score truncated be-
tween [0.1, 0.9] (sample size 4728). Estimates using optimal matching are from Traskin and
Small (2011) based on 1563 optimally matched pairs. Standard errors are calculated via boot-
strapping.
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To compare (truncated) weighting, matching and the proposed “Tudor Solution”, we con-
duct a simulation study closely mimicking the real RHC data. We retain the covariates and the
treatment variable; we generate the outcome from a linear regression model with the treatment
and main effects of the 72 covariates, with coefficients being the ones from fitting such a model
to the real data. We simulate 1000 replicates of the data, each created by sampling with re-
placement 2184 and 3551 units from the treated and control group, respectively. We focus on
the ATT. For weighting, only units with a propensity score between 0.1 and 0.9 are included.
Absolute biases (in 10−2 scale) from the truncated weighting, matching and Tudor analyses
are 1.10, 1.44 and 0.81, respectively, and root mean squared errors (RMSE) are 1.31, 1.75,
and 1.01 respectively. The Tudor solution significantly outperforms matching alone, resulting
in about 40% reduction in both bias and RMSE. This large gain is not surprising given the
high dimensional covariates and the underlying linear outcome model. The Tudor solution also
outperforms truncated weighting, resulting in about 25% reduction in both bias and RMSE.
5.3 A Descriptive Comparison: Racial Disparities in Medical Expendi-
ture
This analysis of racial disparities in medical expenditure uses data similar to that in Leˆ Cook
et al. (2010) for adult respondents aged 18 and older to the 2009 Medical Expenditure Panel
Survey (MEPS); the dataset is publicly available on AHRQ’s website (Agency for Healthcare
Research and Quality, 2012). The sample contains 10,130 non-Hispanic Whites (referred to
as Whites hereafter), 4224 Blacks, 1522 Asians, and 5558 Hispanics. The goal is to estimate
disparities in health care expenditure between Whites and each minority group after balancing
confounding variables. To illustrate, we focus on two separate comparisons – the White-Asian
and White-Hispanic comparisons. Since race is not manipulable, these comparisons are de-
scriptive.
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Here, focusing on ATT or ATE would force us to consider a hypothetical target population
with the covariate distribution of a particular race or a “combined” White-minority population.
Even if such a population is not an infeasible target of inference due to lack of overlap, it may
lack policy relevance for studying disparities because it focuses on individuals atypical for their
own racial/ethnic group. For example, body mass index (BMI) has a much longer and heavier
right tail for Whites than for Asians, so weighting Asians to have a BMI distribution of the
Whites creates an unrealistic population of Asians. Instead, we choose the overlap weights
with the goal of focusing on the naturally comparable subpopulation of people with similar
characteristics: people who, based on their covariates, could easily be either White or from the
minority group.
There are 29 covariates (4 continuous, 25 binary), a mix of health indicators and demo-
graphic variables. We estimate the propensity scores via a logistic regression including all
main effects. For each comparison Z = 1 for Whites and Z = 0 for minority individuals.
The distributions of the estimated propensity scores for the White-Asian and White-Hispanic
comparisons are shown in Figure 3. The White-Asian comparison has severe lack of overlap,
with the largest Asian HT normalized weight being 0.32, meaning that one individual (out of
1522) accounts for almost one third of the total weights of Asians. This weight belongs to an
Asian female with a very high BMI of 55.4 (the highest among Asians) and consequently a
propensity score close to 1. In contrast, the largest overlap normalized weight is only 0.0008.
Figure 4 provides a closer look at the covariate BMI for the White-Asian comparison, show-
ing the unweighted and weighted BMI distributions under each weighting scheme. This illus-
trates the good balance achieved by the overlap weights, and the bad balance and extreme
weight placed on the highest Asian BMI under the inverse probability weighting schemes.
Figure 5 shows boxplots of the ASB for all covariates under each weighting method. As
expected from Theorem 3, the overlap weights always lead to perfect mean balance. For the
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Figure 3: Distribution of the estimated propensity scores for White-Asian and White-Hispanic
comparisons in the MEPS data.
Figure 4: Unweighted and weighted BMI distributions for the White and Asian groups in the
MEPS data.
White-Hispanic comparison, HT and ATT weighting each substantially improved mean balance
compared to the unweighted data, although not as much as overlap weighting. For the White-
Asian comparison, where there is serious lack of overlap in covariates, HT and ATT weighting
results in worse covariate balance than no weighting at all, yielding very large differences in
means for several covariates, including a difference of over 74 unweighted standard errors for
the covariate BMI.
We estimate the weighted average controlled difference in health care expenditure between
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Figure 5: Boxplots for the absolute standardized difference for covariates under each weighting
method.
races using the estimator τˆh. The results with bootstrap standard errors (from 1000 bootstrap
samples) appear in Table 4. Estimates differ substantially across weighting methods, especially
when there is a serious lack of overlap, as in the White-Asian comparison. For example, the
average weighted difference in health care expenditure between Whites and Asians is estimated
to be $2772, $1302, $2458, $2624 from the un-, overlap-, HT- and ATT-weighted methods,
respectively. The IPW weighting methods make the Asian disparity appear to be much greater
than the Hispanic disparity, while this difference is negligible when using the overlap weights.
Overlap weighting focuses on the population where the Whites and minority groups have the
most similar characteristics, and gives the smallest standard error in all the comparisons.
Unweighted (se) Overlap (se) HT (se) ATT (se)
White - Asian 2772.0 (225.1) 1301.9 (220.0) 2457.8 (575.7) 2623.9 (633.8)
White - Hispanic 2562.6 (177.2) 1292.0 (160.5) 511.6 (358.6) 50.8 (508.4)
Table 4: Weighted mean differences in total health care expenditure (dollars) in 2009.
The common practice of discarding or truncating units with propensity scores close to 0
or 1 can make estimates very dependent on the truncation cutoff. We illustrate this by using
HT weights after such truncation or discarding to estimate White - Hispanic disparities. These
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results in Table 5 show estimates changing more than two-fold based on the cutoff choice. In
contrast, the overlap weights avoid this artificial truncation or discarding, and rather continu-
ously and automatically down-weight units with extreme propensity scores.
Estimated Propensity Score Range Kept
[0,1] [0.01, 0.99] [0.05, 0.95] [0.1, 0.9]
Truncate 512 510 1012 1347
Discard 512 446 1247 1166
Table 5: HT weighted mean differences (White - Hispanic) in total health care expenditure
(dollars) in 2009 after truncating or discarding units with extreme propensity scores.
6 Discussion and Extensions
Covariate balance between comparison groups is central to causal and unconfounded descrip-
tive studies. In this paper, we propose a unified framework for the class of weights—the bal-
ancing weights—that balance covariates. Several familiar types of weights, such as the HT
and ATT weights, are special cases. Within this class, we advocate the overlap weights, which
optimize the efficiency of comparisons by defining the population with the most overlap in
the covariates between treatment groups. This weighting method is easy to implement with
standard software and has been used in a number of applications. Though the overlap weights
are statistically motivated, we argue that the corresponding target population and estimand
are often of scientific or policy interest. Our method differs from several published meth-
ods for automated covariate balancing (e.g. Hainmueller, 2012; Graham et al., 2012; Imai and
Ratkovic, 2014) that identify estimates of propensity scores (weights) under certain criterion
(e.g., moment conditions). Rather, we identify a target population that minimizes asymptotic
conditional variance of the treatment effect without preliminary “peeking” at the outcome data,
as in Crump et al. (2006), and then identify additional properties, salutary in applications, of
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the corresponding weights.
The results of Section 3 readily extend under the same assumptions to optimizing a com-
mon target distribution f(x)h(x) for comparisons of J > 2 groups (Imbens, 2000; Imai and van
Dyk, 2004). Suppose ej(x), j = 1, . . . , J are conditional probabilities of assignment to group
j, with
∑
ej(x) = 1, and that the objective is to minimize the sum of the variances of weighted
group means. Then the balancing weights are wj(x) = h(x)/ej(x), and under the conditions
of Corollary 1 they are optimized for h(x) ∝ (∑ 1/ej(x))−1. Extensions to (known) het-
eroscedasticity or to an unequally-weighted objective function are straightforward. However,
comparison of multiple groups allows consideration of a larger selection of propensity score
model specifications than the two-group comparison, as well as different sets of comparisons
of interest. Heuristically, h(·) gives the most relative weight to the covariate regions in which
none of the ej(·) are close to zero. With multiple groups this region of joint overlap might be
small or nonexistent, even if all the pairwise overlaps are substantial. Thus, the suitability of
weighting to a common distribution depends on the specifics of covariate distributions, models,
and scientific objectives of the analysis. Similar issues arise in matching of multiple groups.
Propensity-weighting methods can be readily extended to incorporate sampling weights
(DuGoff et al., 2014), which is arguably an advantage over the matching methods. In one
common approach, the propensity score model eS(x) is estimated using sampling-weighted
estimators, and then observation i with sampling weight Wi and corresponding balancing
weight wS(xi) is weighted by wS(xi)Wi, where wS(xi) = h(xi)/es(xi) for Zi = 1, wS(xi) =
h(xi)/(1− es(xi)) for Zi = 0. The weighted sample distribution is an unbiased and consistent
estimator of the finite population distribution, and the estimation procedure (propensity score
weighting) is consistent when applied to the finite population. On the other hand, the sampling-
weighted estimator is likely to have increased variance if the combined weights wS(xi)Wi are
more variable than the propensity-score weights from the unweighted model wU(xi). Further-
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more, with weighted data the variance estimator and optimality arguments in Section 3 must
be modified because the variance of the weighting estimator is no longer dependent only on
sample size, but also on the weight distribution. Similar issues apply to the method of Zanutto
(2006), which combines unweighted subclassification modeling with weighted estimation of
subclass means. A lively stream of current research aims to recover information from the
weights without the inefficiency of the standard weighted analysis (Zheng and Little, 2005);
these approaches might be productively applied to propensity-score weighting.
Appendix
In what follows we assume regularity conditions on vz and E[Y (z) | X] necessary to make the
integrals defined and convergent.
Proof of Theorem 1. The WATE for the population with density proportional to f(x)h(x) with
respect to base measure µ is defined as
τh =
∫
τ(x)f(x)h(x)µ(dx)
/∫
f(x)h(x)µ(dx)
=
∫
EY,Z|X {Y (1)Z[h(x)/e(x)]− Y (0)(1− Z)[h(x)/(1− e(x))]} f(x)µ(dx)∫
h(x)f(x)µ(dx)
=
∫
EY,Z|X Y (1)Z[h(x)/e(x)]f(x)µ(dx)∫
EZ|X Z[h(x)/e(x)]f(x)µ(dx)
−
∫
EY,Z|X Y0(1− Z)[h(x)/e(x)]f(x)µ(dx)∫
EZ|X(1− Z)[h(x)/e(x)]f(x)µ(dx) (13)
where τ(x) = E[Y (1) − Y (0) | X = x], and using the unconfoundedness assumption that
Y (1), Y (0) ⊥ Z | X . The terms of (13) can be read as expectations of weighted means of
Y (z) in samples drawn from the population with density f(x), respectively for the strata with
z = 1 or z = 0. Replacing expectations by sample means, and substituting weight expressions
from (4), we obtain the following estimator for the sample WATE:
τˆh =
∑
i Yi(1)Ziw1(xi)∑
i Ziw1(xi)
−
∑
i Yi(0)(1− Zi)w0(xi)∑
i(1− Zi)w0(xi)
(14)
26
where each summation (divided by n) is an unbiased estimator of the corresponding integral in
(13); therefore by Slutsky’s theorem τˆh is a consistent estimator of τh.
Proof of Theorem 2. Conditional on the sample X = {x1, . . . , xn} and Z = {z1, . . . , zn},
only Yi is random in (14), so the variance of the estimator τˆh is
V[τˆh | X, z] =
∑
i v1(xi)ziw1(xi)
2
[
∑
i ziw1(xi)]
2 +
∑
i v0(xi)(1− zi)w0(xi)2
[
∑
i(1− zi)w0(xi)]2
=
∑
i v1(xi)[zi/e(xi)][h(xi)
2/e(xi)]
{∑i[zi/e(xi)]h(xi)}2 +
∑
i v0(xi)[(1− zi)/(1− e(xi))][h(xi)2/(1− e(xi))]
{∑i[(1− zi)/(1− e(xi))]h(xi)}2 .
Averaging the above first over the distribution of Z (using E[Zi/e(xi)] = E[(1 − Zi)(1 −
e(xi))] = 1), and then over the distribution of X, and again applying Slutsky’s theorem, we
have
n · ExV[τˆh | X]→
∫ (
v1(x)
e(x)
+
v0(x)
1− e(x)
)
h(x)2f(x)µ(dx)
/(∫
f(x)h(x)µ(dx)
)2
.
Proof of Corollary 1. For simplicity, we use E[·] to denote ∫ ·f(x)µ(dx). According to the
Cauchy-Schwarz inequality, we have
[E {h(x)}]2 =
[
E
{
h(x)√
e(x)(1− e(x))
√
e(x)(1− e(x))
}]2
≤ E
{
h2(x)
e(x)(1− e(x))
}
E [e(x)(1− e(x))] ,
and the equality is attained when h(x)√
e(x)(1−e(x)) ∝
√
e(x)(1− e(x)), that is, when h(x) ∝
e(x)(1− e(x)). Corollary 1 follows directly from applying the above to the right hand side of
(8).
Proof of Theorem 3. The score functions of the logistic propensity score model, logit{e(xi)} =
β0 + xiβ
′ with β = (β1, ..., βK), are:
∂ logL
∂βk
=
∑
i
xik(Zi − eˆi), for k = 0, 1, . . . , K,
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where x0k ≡ 1 and eˆi = [1 + exp(−xiβ′)]−1. Equating to 0 and solving, the MLE βˆ satisfies∑
Zi =
∑
eˆi, and
∑
xikZi =
∑
xikeˆi.
It follows that
∑
i
Zi(1− eˆi) =
∑
eˆi −
∑
i
Zieˆi =
∑
eˆi(1− Zi),∑
i
xikZi(1− eˆi) =
∑
xikeˆi −
∑
i
xikZieˆi =
∑
xikeˆi(1− Zi), for k = 1, . . . , K.
Therefore, for any k = 1, . . . , K, we have∑
i xikZi(1− eˆi)∑
i Zi(1− eˆi)
=
∑
i xik(1− Zi)eˆi∑
i(1− Zi)eˆi
.
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